Search
Search Funnelback University
- Refined by:
- Format: pdf
Your query has been expanded to TALK:PC53 20 |u:www.enterprize.cam.ac.uk. Search for TALK:PC53 20 |u:www.enterprise.cam.ac.uk instead.
1 -
20 of
41
search results for TALK:PC53 20 |u:www.enterprise.cam.ac.uk or TALK:PC53 20 |u:www.enterprize.cam.ac.uk
where 0
match all words and 41
match some words.
Results that match 1 of 2 words
-
NMC coating information sheet (Gre-7694-20)
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/03/NMC-coating-information-sheet-Gre-7694-20.pdf9 Feb 2022: Single-source precursors for multiple-function coatings Case Ref: Gre-7694-20. Dr Tim RosserCommercialisation Associatetim.rosser@enterprise.cam.ac.uk. -
Mouse Models of Essential Thrombocythemia (ET) and Myelofibrosis (MF) …
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2388814 Jul 2024: Page 2/5 Reference number: GRE-7381-20. Reduced number of erythroblasts (Figure B). ... Powered by TCPDF (www.tcpdf.org). Page 5/5 Reference number: GRE-7381-20. -
Enabling High Data Rates-Pen-7846-20
https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/07/Information-sheet-Enabling-High-Data-Rates-Pen-7846-20.pdf14 Jul 2021: Case Ref: Pen-7846-20. Dr Gillian DavisCommercialisation Directorgillian.davis@enterprise.cam.ac.uk. Richard Penty is Professor of Photonics in the Department of Engineering at the University of Cambridge. -
Neonatal wireless transmission system
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2629814 Jul 2024: Page 2/4 Reference number: BON-7603-20. and blood oxygen levels (pulse oximetry). ... Powered by TCPDF (www.tcpdf.org). Page 4/4 Reference number: BON-7603-20. -
Redox flow SOC measurement information sheet (Gre-7712-20)
https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/11/Redox-flow-SOC-measurement-information-sheet-Gre-7712-20.pdf9 Mar 2022: Reliable redox flow battery state-of-charge measurement. A low cost, in line technique to maintain optimal performance Case Ref: Gre-7712-20. -
Planarific: AI-based software for sustainable retrofitting and design
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2692814 Jul 2024: Page 1/4 Reference number: XIA-7922-20. A CHALLENGE IN RETROFITTING AGING HOUSING STOCK IS SUPPLY-SIDE SHORTAGE IN DESIGN & CONSTRUCTION. ... Page 2/4 Reference number: XIA-7922-20. Informed by these estimates, homeowners can make key decisions -
Implantable drug delivery device targeting brain tumours
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2629614 Jul 2024: Page 1/3 Reference number: MAL-7401-20. and safety problems to deliver drugs to hard-to-reach brain tumours. ... Powered by TCPDF (www.tcpdf.org). Page 3/3 Reference number: MAL-7401-20. -
Cathode coatings for NMC batteries
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2626414 Jul 2024: Page 1/2 Reference number: GRE-7694-20. Benefits. Improved lifetime of NMC cathodes without compromising capacity of Li-ion batteries. ... Powered by TCPDF (www.tcpdf.org). Page 2/2 Reference number: GRE-7694-20. -
LGR5 monoclonal antibody for cancer immunotherapy
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2357214 Jul 2024: Page 2/8 Reference number: DE-7580-20. α-LGR5 Bispecific T cell Engagers (BiTEs). ... α-LGR5 BiTE activates T cells leading to efficienttumour cell destruction. Page 3/8 Reference number: DE-7580-20. -
Annual Review2019 /Where ideas thrive 2 Cambridge Enterprise Annual…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/03/Cambridge-Enterprise-Annual-Review-2019-1.pdf4 Mar 2020: In 1995, Molecular Simulations was acquired by Accelrys Inc., which handled sales of CASTEP for almost 20 years. ... 20 Cambridge Enterprise Annual Review 2019. 2018-19 £’000. 2017-18£’000. Income generated by Cambridge Enterprise operations 11,003 -
High energy density lithium-sulfur batteries
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2628014 Jul 2024: Have been successfully fabricated and demonstrated. Patents. PCT Application EP2022/076077 (priority date 20 September 2021). -
MAT2A inhibitors to treat BK polyomavirus disease
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2810214 Jul 2024: Benefits. Technology is the first specific treatment for BKPyV-associated diseases(e.g. PVAN and HC) in immunosuppressed patients, holding the potentialto benefit around 20,000 affected transplant recipients annually. ... criticalhost factor for BK -
PowerPoint Presentation
https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/06/patent-publication-timeline.pdf20 Jun 2021: National application 3. National application 2. National application 1. Monopoly for 20 years from priority filing. -
Ortho-quinone prodrug strategy (self-immolative linkers)
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2318714 Jul 2024: Release of β-lapachone from peptide prodrug. Release of β-lapachone 1 from peptide prodrug 26 at 254 nm after in vitro dipeptide cleavage byprotease cathepsin B (MES 20 mM buffer, -
Versatile Electronic Fibre
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2712314 Jul 2024: Fibers are washable (AAATCC standard) with Iph,wash/Iph,nowash 94%and72% at 20 and 30 cycles. -
Innovation.Partnership.Impact. ANNUAL REVIEW 2023 The University of…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/CE_Annual_Report23_WEB.pdf26 Mar 2024: 18 NuQuantum: pioneering Quantum Networking for transformative computing. 20 Establishing a home-grown, inclusive innovation roadmap to prosperity for Greater Cambridge. ... 06 OCTOBER. 20 MARCH. £29.8bn economic impact of the University of Cambridge -
Electronic nose
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2628314 Jul 2024: Low barrier to entry agritech market. Each year, between 20-40% of crops are expected to be lost worldwide todisease. -
Potential uses: • High throughput drug screening for therapeutic ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2011/09/Sin-2591-11V6_29052019.pdf29 May 2019: display contractile ability in response to carbachol treatment. There was a 10-20% change of surface area in contracting cells. -
patent process
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/patent-application-process.pdf7 Jul 2015: 0 months. Monopoly for 20 years from filing. 6 months 12 months 18 months 24 months 30 months 5 years. -
PowerPoint Presentation
https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/04/Cambridge-Enterprise-Virus-Research-Reagents.pdf28 Apr 2020: 2009, 90,1202. J Virol. 2010, 84(20), 10937. 2. Herpes Simplex Virus Type 1 and 2 (HSV-1 and -2) antibodies.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.